Laetitia SzallerGeneral Counsel and VP Business Development at AM Pharma
Laetitia has over 20 years’ experience in multiple sectors, including 15 in the pharmaceuticals and medical device industry, leading and managing complex multi-jurisdiction operations including global multi-million M&A deals, licensing and collaboration partnerships. At AM-Pharma, she is responsible for both the Legal operations and the Corporate Development of the company. Prior to joining AM-Pharma in April 2020 as General Counsel, VP Corporate Development and Corporate Secretary, she was at UCB as global Associate General Counsel BD, M&A and Antitrust. Prior to UCB, Laetitia was Legal Director, Emerging Markets EMEA, Central European Region and Benelux at Zoetis (Pfizer former animal health division), and has also led the EMEA legal department for the Abbott Vascular division at Abbott. She also held global positions at the Carlson Rezidor Hotel Group and at the automotive division (Wabco) at American Standard. Laetitia is a qualified lawyer in both the UK and Belgium, with extensive international experience, regularly speaking at various legal conferences.
Opening Remarks from Chair, 08:50View Session
PANEL: Data Sharing Antitrust Risks in Collaborations and Transactions, 11:20View Session